Letters New Zealand law on new psychoactive substances

The need for sustainable regulation of tobacco products

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2033 (Published 10 March 2014) Cite this as: BMJ 2014;348:g2033
  1. Richard Edwards, professor1,
  2. Nick Wilson, associate professor1
  1. 1ASPIRE 2025, Department of Public Health, University of Otago, Wellington, New Zealand
  1. richard.edwards{at}otago.ac.nz

Newberry and colleagues draw attention to New Zealand’s new Psychoactive Substances Act,1 a novel and potentially more sustainable approach to the regulation of these substances. Key aspects of this law are the onus put on drug manufacturers to show that their products pose only a low risk of harm and the stringent restrictions on the sale and supply of these substances.

However, the authors incorrectly state that this new …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe